These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 20502423)

  • 1. The role of immune activation in contributing to vascular dysfunction and the pathophysiology of hypertension during preeclampsia.
    Lamarca B
    Minerva Ginecol; 2010 Apr; 62(2):105-20. PubMed ID: 20502423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial dysfunction. An important mediator in the pathophysiology of hypertension during pre-eclampsia.
    Lamarca B
    Minerva Ginecol; 2012 Aug; 64(4):309-20. PubMed ID: 22728575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioactive factors in uteroplacental and systemic circulation link placental ischemia to generalized vascular dysfunction in hypertensive pregnancy and preeclampsia.
    Shah DA; Khalil RA
    Biochem Pharmacol; 2015 Jun; 95(4):211-26. PubMed ID: 25916268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction.
    Gilbert JS; Ryan MJ; LaMarca BB; Sedeek M; Murphy SR; Granger JP
    Am J Physiol Heart Circ Physiol; 2008 Feb; 294(2):H541-50. PubMed ID: 18055511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of Endothelial Dysfunction in Hypertensive Pregnancy and Preeclampsia.
    Possomato-Vieira JS; Khalil RA
    Adv Pharmacol; 2016; 77():361-431. PubMed ID: 27451103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiology of preeclampsia: linking placental ischemia/hypoxia with microvascular dysfunction.
    Granger JP; Alexander BT; Llinas MT; Bennett WA; Khalil RA
    Microcirculation; 2002 Jul; 9(3):147-60. PubMed ID: 12080413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology of hypertension during preeclampsia linking placental ischemia with endothelial dysfunction.
    Granger JP; Alexander BT; Llinas MT; Bennett WA; Khalil RA
    Hypertension; 2001 Sep; 38(3 Pt 2):718-22. PubMed ID: 11566964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Endothelin System: A Critical Player in the Pathophysiology of Preeclampsia.
    Granger JP; Spradley FT; Bakrania BA
    Curr Hypertens Rep; 2018 Apr; 20(4):32. PubMed ID: 29637419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular mechanisms of increased arterial pressure in preeclampsia: lessons from animal models.
    Khalil RA; Granger JP
    Am J Physiol Regul Integr Comp Physiol; 2002 Jul; 283(1):R29-45. PubMed ID: 12069928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A leading role for the immune system in the pathophysiology of preeclampsia.
    Laresgoiti-Servitje E
    J Leukoc Biol; 2013 Aug; 94(2):247-57. PubMed ID: 23633414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early disturbed placental ischemia and hypoxia creates immune alteration and vascular disorder causing preeclampsia.
    Zárate A; Saucedo R; Valencia J; Manuel L; Hernández M
    Arch Med Res; 2014 Oct; 45(7):519-24. PubMed ID: 25450587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurovascular mechanisms of hypertension in pregnancy.
    Stennett AK; Khalil RA
    Curr Neurovasc Res; 2006 May; 3(2):131-48. PubMed ID: 16719796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular mechanisms and molecular targets in hypertensive pregnancy and preeclampsia.
    Qu H; Khalil RA
    Am J Physiol Heart Circ Physiol; 2020 Sep; 319(3):H661-H681. PubMed ID: 32762557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D Supplementation Prevents Placental Ischemia Induced Endothelial Dysfunction by Downregulating Placental Soluble FMS-Like Tyrosine Kinase-1.
    Ma SL; Tian XY; Wang YQ; Zhang HF; Zhang L
    DNA Cell Biol; 2017 Dec; 36(12):1134-1141. PubMed ID: 28981319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiology of pregnancy-induced hypertension.
    Granger JP; Alexander BT; Bennett WA; Khalil RA
    Am J Hypertens; 2001 Jun; 14(6 Pt 2):178S-185S. PubMed ID: 11411754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trophoblastic remodeling in normal and preeclamptic pregnancies: implication of cytokines.
    Kharfi A; Giguère Y; Sapin V; Massé J; Dastugue B; Forest JC
    Clin Biochem; 2003 Jul; 36(5):323-31. PubMed ID: 12849862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular biology of preeclampsia.
    Myatt L; Webster RP
    J Thromb Haemost; 2009 Mar; 7(3):375-84. PubMed ID: 19087223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic, immune and vasoactive factors in the vascular dysfunction associated with hypertension in pregnancy.
    Ali SM; Khalil RA
    Expert Opin Ther Targets; 2015; 19(11):1495-515. PubMed ID: 26294111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pathophysiology of preeclampsia involves altered levels of angiogenic factors promoted by hypoxia and autoantibody-mediated mechanisms.
    Laresgoiti-Servitje E; Gomez-Lopez N
    Biol Reprod; 2012 Aug; 87(2):36. PubMed ID: 22649072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agonistic autoantibodies to the angiotensin II type I receptor cause pathophysiologic characteristics of preeclampsia.
    LaMarca B; Parrish MR; Wallace K
    Gend Med; 2012 Jun; 9(3):139-46. PubMed ID: 22498426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.